Permanent implants using Au-198, Pd-103 and I-125: Radiobiological considerations based on the linear quadratic model
- 1 January 1992
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 23 (1) , 81-87
- https://doi.org/10.1016/0360-3016(92)90546-t
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The linear-quadratic formula and progress in fractionated radiotherapyThe British Journal of Radiology, 1989
- Radiobiological assessment of permanent implants using tumour repopulation factors in the linear-quadratic modelThe British Journal of Radiology, 1989
- The utilization of I-125 seeds as a substitute for Ir-192 seeds in temporary interstitial implants: An overview and a description of the william beaumont hospital techniqueInternational Journal of Radiation Oncology*Biology*Physics, 1988
- BrachytherapyAmerican Journal of Clinical Oncology, 1988
- Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: Intratumour sampling variationsRadiotherapy and Oncology, 1988
- The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapyThe British Journal of Radiology, 1985
- Relative biological effectiveness of 125 sources in a murine brachytherapy modelInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Physical dosimetry of 125I seeds of a new design for interstitial implantInternational Journal of Radiation Oncology*Biology*Physics, 1983
- Studies with encapsulated 125I sources. II. determination of the relative biological effectiveness using cultured mammalian cellsInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Radiation Dose-Rate: A Factor of Importance in Radiobiology and RadiotherapyThe British Journal of Radiology, 1972